Featured Research

from universities, journals, and other organizations

Effects of Antioxidant Supplements On Cancer Are Mixed

Date:
January 20, 2008
Source:
Mayo Clinic
Summary:
Do antioxidant supplements reduce the risk of cancer and deaths related to cancer? While some trials have suggested that antioxidants have beneficial effects, results from other trials have been negative. It has been unclear which antioxidant compounds are more beneficial (or more harmful), and how individual antioxidants affect target organs and specific patient populations. To examine these issues, Mayo researchers conducted a systematic review on the topic.

Do antioxidant supplements reduce the risk of cancer and deaths related to cancer? While some trials have suggested that antioxidants have beneficial effects, results from other trials have been negative. It has been unclear which antioxidant compounds are more beneficial (or more harmful), and how individual antioxidants affect target organs and specific patient populations. To examine these issues, Mayo researchers conducted a systematic review on the topic.

"Systematic reviews can provide reliable summaries of the research, and help understand why different studies give different results," says Victor Montori, M.D., senior author on the study and lead for Mayo Clinic's Knowledge and Encounter Research (KER) unit. For the study, two authors reviewed all randomized trials on antioxidants for cancer prevention(1968-2005) and identified 12 clinical trials with a total eligible population of 104,196.

The review yielded a number of interesting findings including:

  • Overall, antioxidant supplementation did not reduce the risk of cancer.
  • Beta carotene supplementation was actually found to increase the risk of smoking-related cancers, as well as cancer mortality, and thus should be avoided, especially by tobacco users.
  • Vitamin E appeared to have no beneficial or harmful effects.
  • Selenium supplementation was found to lower the risk of cancer in men (not in women), but the number of trials were few and further research is required. A large trial assessing the effect of selenium in lowering the risk of prostate cancer is currently underway.

The bottom line according to Aditya Bardia, M.D., lead author of the study, is that antioxidants do not lower the risk of cancer and beta carotene might actually increase cancer risk among smokers. Selenium might have beneficial properties, but it cannot be recommended for general use until more evidence is available.

This research is published in an article in the January issue of Mayo Clinic Proceedings. In addition to Drs. Montori and Bardia, authors of the article include James Cerhan, M.D., Ph.D.; Amit Sood, M.D.; Paul Limburg, M.D.; and Patricia Erwin, all of Mayo Clinic; and Imad Tleyjeh, M.D., King Fahd Medical City, Riyadh, Saudi Arabia.


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Effects of Antioxidant Supplements On Cancer Are Mixed." ScienceDaily. ScienceDaily, 20 January 2008. <www.sciencedaily.com/releases/2008/01/080118133308.htm>.
Mayo Clinic. (2008, January 20). Effects of Antioxidant Supplements On Cancer Are Mixed. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/01/080118133308.htm
Mayo Clinic. "Effects of Antioxidant Supplements On Cancer Are Mixed." ScienceDaily. www.sciencedaily.com/releases/2008/01/080118133308.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins